{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:40:19Z","timestamp":1793932819400,"version":"4.8.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","award":["10312"],"award-info":[{"award-number":["10312"]}],"id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000346","name":"Ataxia UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EndFA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Friedreich ataxia (FRDA) is a rare genetic multisystem disorder caused by a pathological GAA trinucleotide repeat expansion in the <jats:italic>FXN<\/jats:italic> gene. The numerous drawbacks of historical cellular and rodent models of FRDA have caused difficulty in performing effective mechanistic and translational studies to investigate the disease. The recent discovery and subsequent development of induced pluripotent stem cell (iPSC) technology provides an exciting platform to enable enhanced disease modelling for studies of rare genetic diseases. Utilising iPSCs, researchers have created phenotypically relevant and previously inaccessible cellular models of FRDA. These models enable studies of the molecular mechanisms underlying GAA-induced pathology, as well as providing an exciting tool for the screening and testing of novel disease-modifying therapies. This review explores how the use of iPSCs to study FRDA has developed over the past decade, as well as discussing the enormous therapeutic potentials of iPSC-derived models, their current limitations and their future direction within the field of FRDA research.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s40035-023-00376-8","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T03:27:24Z","timestamp":1695180444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application"],"prefix":"10.1186","volume":"12","author":[{"given":"Saumya","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Vilema-Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wade-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"issue":"1","key":"376_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg.37.1.1","volume":"37","author":"MB Delatycki","year":"2000","unstructured":"Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet. 2000;37(1):1\u20138.","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"376_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","volume":"303","author":"AH Koeppen","year":"2011","unstructured":"Koeppen AH. Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303(1\u20132):1\u201312.","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"376_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","volume":"256","author":"M Pandolfo","year":"2009","unstructured":"Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3\u20138.","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"376_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jnc.12219","volume":"126","author":"M Perdomini","year":"2013","unstructured":"Perdomini M, Hick A, Puccio H, Pook MA. Animal and cellular models of Friedreich ataxia. J Neurochem. 2013;126(Suppl 1):65\u201379.","journal-title":"J Neurochem"},{"issue":"4","key":"376_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"3","key":"376_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/er.2008-0031","volume":"30","author":"B Lo","year":"2009","unstructured":"Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30(3):204\u201313.","journal-title":"Endocr Rev"},{"issue":"R1","key":"376_CR7","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1093\/hmg\/ddu204","volume":"23","author":"CA Ross","year":"2014","unstructured":"Ross CA, Akimov SS. Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet. 2014;23(R1):R17-26.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"376_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.stem.2010.09.014","volume":"7","author":"S Ku","year":"2010","unstructured":"Ku S, Soragni E, Campau E, Thomas EA, Altun G, Laurent LC, et al. Friedreich\u2019s ataxia induced pluripotent stem cells model intergenerational GAA\u22c5TTC triplet repeat instability. Cell Stem Cell. 2010;7(5):631\u20137.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"376_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s12015-010-9210-x","volume":"7","author":"J Liu","year":"2011","unstructured":"Liu J, Verma PJ, Evans-Galea MV, Delatycki MB, Michalska A, Leung J, et al. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev. 2011;7(3):703\u201313.","journal-title":"Stem Cell Rev"},{"issue":"3","key":"376_CR10","first-page":"608","volume":"6","author":"A Hick","year":"2013","unstructured":"Hick A, Wattenhofer-Donz\u00e9 M, Chintawar S, Tropel P, Simard JP, Vaucamps N, et al. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich\u2019s ataxia. Dis Model Mech. 2013;6(3):608\u201321.","journal-title":"Dis Model Mech"},{"issue":"1","key":"376_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-019-1305-y","volume":"10","author":"AO-T Wong","year":"2019","unstructured":"Wong AO, Wong G, Shen M, Chow MZ, Tse WW, Gurung B, et al. Correlation between frataxin expression and contractility revealed by in vitro Friedreich\u2019s ataxia cardiac tissue models engineered from human pluripotent stem cells. Stem Cell Res Ther. 2019;10(1):203.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"376_CR12","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1038\/s41467-020-17954-3","volume":"11","author":"PG Mazzara","year":"2020","unstructured":"Mazzara PG, Muggeo S, Luoni M, Massimino L, Zaghi M, Valverde PT, et al. Frataxin gene editing rescues Friedreich\u2019s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons. Nat Commun. 2020;11(1):4178.","journal-title":"Nat Commun"},{"issue":"1","key":"376_CR13","doi-asserted-by":"publisher","first-page":"7752","DOI":"10.1038\/s41598-020-64831-6","volume":"10","author":"C Dionisi","year":"2020","unstructured":"Dionisi C, Rai M, Chazalon M, Schiffmann SN, Pandolfo M. Primary proprioceptive neurons from human induced pluripotent stem cells: a cell model for afferent ataxias. Sci Rep. 2020;10(1):7752.","journal-title":"Sci Rep"},{"issue":"9","key":"376_CR14","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00424-013-1414-x","volume":"466","author":"Y-K Lee","year":"2014","unstructured":"Lee YK, Ho PW, Schick R, Lau YM, Lai WH, Zhou T, et al. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Pflugers Arch. 2014;466(9):1831\u201344.","journal-title":"Pflugers Arch"},{"issue":"7","key":"376_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101718","volume":"9","author":"MJ Bird","year":"2014","unstructured":"Bird MJ, Needham K, Frazier AE, van Rooijen J, Leung J, Hough S, et al. Functional characterization of Friedreich ataxia iPS-derived neuronal progenitors and their integration in the adult brain. PLoS ONE. 2014;9(7): e101718.","journal-title":"PLoS ONE"},{"key":"376_CR16","first-page":"141","volume":"4","author":"DE Crombie","year":"2015","unstructured":"Crombie DE, Van Bergen N, Davidson KC, Anjomani Virmouni S, Mckelvie PA, Chrysostomou V, et al. Characterization of the retinal pigment epithelium in Friedreich ataxia. Biochem Biophys Rep. 2015;4:141\u20137.","journal-title":"Biochem Biophys Rep"},{"issue":"5","key":"376_CR17","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.18632\/aging.101247","volume":"9","author":"DE Crombie","year":"2017","unstructured":"Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, et al. Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging (Albany NY). 2017;9(5):1440\u201352.","journal-title":"Aging (Albany NY)"},{"issue":"2019","key":"376_CR18","first-page":"7623023","volume":"27","author":"A Bolotta","year":"2019","unstructured":"Bolotta A, Abruzzo PM, Baldassarro VA, Ghezzo A, Scotlandi K, Marini M, et al. New Insights into the hepcidin-ferroportin axis and iron homeostasis in iPSC-derived cardiomyocytes from Friedreich\u2019s Ataxia patient. Oxid Med Cell Longev. 2019;27(2019):7623023.","journal-title":"Oxid Med Cell Longev"},{"issue":"35","key":"376_CR19","doi-asserted-by":"publisher","first-page":"29861","DOI":"10.1074\/jbc.M112.391961","volume":"287","author":"J Du","year":"2012","unstructured":"Du J, Campau E, Soragni E, Ku S, Puckett JW, Dervan PB, et al. Role of mismatch repair enzymes in GAA\u00b7TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells. J Biol Chem. 2012;287(35):29861\u201372.","journal-title":"J Biol Chem"},{"issue":"24","key":"376_CR20","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1089\/scd.2013.0126","volume":"22","author":"A Eigentler","year":"2013","unstructured":"Eigentler A, Boesch S, Schneider R, Dechant G, Nat R. Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons. Stem Cells Dev. 2013;22(24):3271\u201382.","journal-title":"Stem Cells Dev"},{"issue":"11","key":"376_CR21","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1021\/pr500514r","volume":"13","author":"B Shan","year":"2014","unstructured":"Shan B, Xu C, Zhang Y, Xu T, Gottesfeld JM, Yates JR. Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich\u2019s ataxia patient iPSC-derived neural stem cells. J Proteome Res. 2014;13(11):4558\u201366.","journal-title":"J Proteome Res"},{"issue":"8","key":"376_CR22","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/hmg\/ddu745","volume":"24","author":"M Igoillo-Esteve","year":"2015","unstructured":"Igoillo-Esteve M, Gurgul-Convey E, Hu A, Romagueira Bichara Dos Santos L, Abdulkarim B, Chintawar S, et al. Unveiling a common mechanism of apoptosis in \u03b2-cells and neurons in Friedreich\u2019s ataxia. Hum Mol Genet. 2015;24(8):2274\u201386.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"376_CR23","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1093\/hmg\/ddaa267","volume":"29","author":"LN Rodden","year":"2021","unstructured":"Rodden LN, Chutake YK, Gilliam K, Lam C, Soragni E, Hauser L, et al. Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia. Hum Mol Genet. 2021;29(23):3818\u201329.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"376_CR24","doi-asserted-by":"publisher","first-page":"dmm049497","DOI":"10.1242\/dmm.049497","volume":"16","author":"MG Cotticelli","year":"2023","unstructured":"Cotticelli MG, Xia S, Truitt R, Doliba NM, Rozo AV, Tobias JW, et al. Acute frataxin knockdown in induced pluripotent stem cell-derived cardiomyocytes activates a type I interferon response. Dis Model Mech. 2023;16(5):dmm049497.","journal-title":"Dis Model Mech"},{"key":"376_CR25","doi-asserted-by":"publisher","first-page":"e2093","DOI":"10.1002\/mgg3.2093","volume":"11","author":"MB Angulo","year":"2022","unstructured":"Angulo MB, Bertalovitz A, Argenziano MA, Yang J, Patel A, Zesiewicz T, et al. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes. Mol Genet Genomic Med. 2022;11:e2093.","journal-title":"Mol Genet Genomic Med"},{"issue":"10","key":"376_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/archneur.65.10.1296","volume":"65","author":"M Pandolfo","year":"2008","unstructured":"Pandolfo M. Friedreich ataxia. Arch Neurol. 2008;65(10):1296\u2013303.","journal-title":"Arch Neurol"},{"issue":"8","key":"376_CR27","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","volume":"26","author":"F Piguet","year":"2018","unstructured":"Piguet F, de Montigny C, Vaucamps N, Reutenauer L, Eisenmann A, Puccio H. Rapid and complete reversal of sensory ataxia by gene therapy in a novel model of friedreich ataxia. Mol Ther. 2018;26(8):1940\u201352.","journal-title":"Mol Ther"},{"issue":"6","key":"376_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00401-009-0589-x","volume":"118","author":"AH Koeppen","year":"2009","unstructured":"Koeppen AH, Morral JA, Davis AN, Qian J, Petrocine SV, Knutson MD, et al. The dorsal root ganglion in Friedreich\u2019s ataxia. Acta Neuropathol. 2009;118(6):763\u201376.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"376_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","volume":"307","author":"AY Tsou","year":"2011","unstructured":"Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307(1\u20132):46\u20139.","journal-title":"J Neurol Sci"},{"issue":"4","key":"376_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1017\/S0317167100025609","volume":"3","author":"D Shapcott","year":"1976","unstructured":"Shapcott D, Melancon S, Butterworth RF, Khoury K, Collu R, Breton G, et al. Glucose and insulin metabolism in Friedreich\u2019s ataxia. Can J Neurol Sci. 1976;3(4):361\u20134.","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"376_CR31","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1212\/WNL.38.8.1292","volume":"38","author":"G Finocchiaro","year":"1988","unstructured":"Finocchiaro G, Baio G, Micossi P, Pozza G, di Donato S. Glucose metabolism alterations in Friedreich\u2019s ataxia. Neurology. 1988;38(8):1292\u20136.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"376_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jnc.12216","volume":"126","author":"M Cnop","year":"2013","unstructured":"Cnop M, Mulder H, Igoillo-Esteve M. Diabetes in Friedreich ataxia. J Neurochem. 2013;126(Suppl 1):94\u2013102.","journal-title":"J Neurochem"},{"issue":"6","key":"376_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ana.23698","volume":"72","author":"M Cnop","year":"2012","unstructured":"Cnop M, Igoillo-Esteve M, Rai M, Begu A, Serroukh Y, Depondt C, et al. Central role and mechanisms of \u03b2-cell dysfunction and death in friedreich ataxia-associated diabetes. Ann Neurol. 2012;72(6):971\u201382.","journal-title":"Ann Neurol"},{"issue":"1","key":"376_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13287-018-1099-3","volume":"9","author":"HM Shahjalal","year":"2018","unstructured":"Shahjalal HM, Abdal Dayem A, Lim KM, Jeon TI, Cho SG. Generation of pancreatic \u03b2 cells for treatment of diabetes: advances and challenges. Stem Cell Res Ther. 2018;9(1):355.","journal-title":"Stem Cell Res Ther"},{"key":"376_CR35","doi-asserted-by":"crossref","unstructured":"Igoillo-Esteve M, Oliveira AF, Cosentino C, Fantuzzi F, Demarez C, Toivonen S, et al. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. JCI Insight. 2020;5(2):e134221.","DOI":"10.1172\/jci.insight.134221"},{"issue":"9","key":"376_CR36","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s00415-013-6978-z","volume":"260","author":"LA Seyer","year":"2013","unstructured":"Seyer LA, Galetta K, Wilson J, Sakai R, Perlman S, Mathews K, et al. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013;260(9):2362\u20139.","journal-title":"J Neurol"},{"issue":"2","key":"376_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/eye.2011.291","volume":"26","author":"S Noval","year":"2012","unstructured":"Noval S, Contreras I, Sanz-Gallego I, Manrique RK, Arpa J. Ophthalmic features of Friedreich ataxia. Eye (Lond). 2012;26(2):315\u201320.","journal-title":"Eye (Lond)"},{"issue":"Pt 1","key":"376_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/brain\/awn269","volume":"132","author":"F Fortuna","year":"2009","unstructured":"Fortuna F, Barboni P, Liguori R, Valentino ML, Savini G, Gellera C, et al. Visual system involvement in patients with Friedreich\u2019s ataxia. Brain. 2009;132(Pt 1):116\u201323.","journal-title":"Brain"},{"issue":"11","key":"376_CR39","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/archopht.121.11.1582","volume":"121","author":"CD Alldredge","year":"2003","unstructured":"Alldredge CD, Schlieve CR, Miller NR, Levin LA. Pathophysiology of the optic neuropathy associated with Friedreich ataxia. Arch Ophthalmol. 2003;121(11):1582\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"376_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/WNO.0000000000000068","volume":"34","author":"E Da\u011f","year":"2014","unstructured":"Da\u011f E, \u00d6rnek N, \u00d6rnek K, Erbah\u00e7eci-Timur IE. Optical coherence tomography and visual field findings in patients with Friedreich ataxia. J Neuroophthalmol. 2014;34(2):118\u201321.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"376_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, et al. Safety and efficacy of omaveloxolone in friedreich ataxia (moxie study). Ann Neurol. 2021;89(2):212\u201325.","journal-title":"Ann Neurol"},{"issue":"4","key":"376_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.24260","volume":"76","author":"E Soragni","year":"2014","unstructured":"Soragni E, Miao W, Iudicello M, Jacoby D, De Mercanti S, Clerico M, et al. Epigenetic therapy for Friedreich ataxia. Ann Neurol. 2014;76(4):489\u2013508.","journal-title":"Ann Neurol"},{"issue":"6","key":"376_CR43","first-page":"44","volume":"5","author":"E Soragni","year":"2015","unstructured":"Soragni E, Chou CJ, Rusche JR, Gottesfeld JM. Mechanism of action of 2-Aminobenzamide HDAC inhibitors in reversing gene silencing in Friedreich\u2019s ataxia. Front Neurol. 2015;5(6):44.","journal-title":"Front Neurol"},{"issue":"22","key":"376_CR44","first-page":"4847","volume":"25","author":"F Codazzi","year":"2016","unstructured":"Codazzi F, Hu A, Rai M, Donatello S, Salerno Scarzella F, Mangiameli E, et al. Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor. Hum Mol Genet. 2016;25(22):4847\u201355.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"376_CR45","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1089\/scd.2016.0147","volume":"25","author":"U Polak","year":"2016","unstructured":"Polak U, Li Y, Butler JS, Napierala M. Alleviating GAA repeat induced transcriptional silencing of the friedreich\u2019s ataxia gene during somatic cell reprogramming. Stem Cells Dev. 2016;25(23):1788\u2013800.","journal-title":"Stem Cells Dev"},{"key":"376_CR46","doi-asserted-by":"publisher","unstructured":"Hu A, Rai M, Donatello S, Pandolfo M. Oxidative stress and loss of Fe-S proteins in Friedreich ataxia induced pluripotent stem cell-derived PSNs can be reversed by restoring FXN expression with a benzamide HDAC inhibitor. BioRxiv. 2017;221242.  https:\/\/doi.org\/10.1101\/221242.","DOI":"10.1101\/221242"},{"issue":"6","key":"376_CR47","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1074\/jbc.RA118.006515","volume":"294","author":"JI Lai","year":"2019","unstructured":"Lai JI, Nachun D, Petrosyan L, Throesch B, Campau E, Gao F, et al. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. J Biol Chem. 2019;294(6):1846\u201359.","journal-title":"J Biol Chem"},{"issue":"1","key":"376_CR48","doi-asserted-by":"publisher","first-page":"14568","DOI":"10.1038\/s41598-019-49870-y","volume":"9","author":"P Georges","year":"2019","unstructured":"Georges P, Boza-Moran M-G, Gide J, P\u00eache GA, For\u00eat B, Bayot A, et al. Induced pluripotent stem cells-derived neurons from patients with Friedreich ataxia exhibit differential sensitivity to resveratrol and nicotinamide. Sci Rep. 2019;9(1):14568.","journal-title":"Sci Rep"},{"issue":"16","key":"376_CR49","doi-asserted-by":"publisher","first-page":"836476","DOI":"10.3389\/fnins.2022.836476","volume":"23","author":"AM Schreiber","year":"2022","unstructured":"Schreiber AM, Li Y, Chen YH, Napierala JS, Napierala M. Selected histone deacetylase inhibitors reverse the frataxin transcriptional defect in a novel Friedreich\u2019s ataxia induced pluripotent stem cell-derived neuronal reporter system. Front Neurosci. 2022;23(16):836476.","journal-title":"Front Neurosci"},{"issue":"5","key":"376_CR50","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2016.06.075","volume":"16","author":"J Gerhardt","year":"2016","unstructured":"Gerhardt J, Bhalla AD, Butler JS, Puckett JW, Dervan PB, Rosenwaks Z, et al. Stalled DNA replication forks at the endogenous GAA repeats drive repeat expansion in friedreich\u2019s ataxia cells. Cell Rep. 2016;16(5):1218\u201327.","journal-title":"Cell Rep"},{"issue":"203","key":"376_CR51","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ijcard.2015.11.101","volume":"15","author":"YK Lee","year":"2016","unstructured":"Lee YK, Lau YM, Ng KM, Lai WH, Ho SL, Tse HF, et al. Efficient attenuation of Friedreich\u2019s ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA. Int J Cardiol. 2016;15(203):964\u201371.","journal-title":"Int J Cardiol"},{"issue":"6370","key":"376_CR52","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1126\/science.aan6414","volume":"358","author":"GS Erwin","year":"2017","unstructured":"Erwin GS, Grieshop MP, Ali A, Qi J, Lawlor M, Kumar D, et al. Synthetic transcription elongation factors license transcription across repressive chromatin. Science. 2017;358(6370):1617\u201322.","journal-title":"Science"},{"issue":"20","key":"376_CR53","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1093\/nar\/gkab954","volume":"49","author":"Y Li","year":"2021","unstructured":"Li Y, Li J, Wang J, Lynch DR, Shen X, Corey DR, et al. Targeting 3\u2019 and 5\u2019 untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression. Nucleic Acids Res. 2021;49(20):11560\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"6934","key":"376_CR54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nature01596","volume":"422","author":"A Saveliev","year":"2003","unstructured":"Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R. DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature. 2003;422(6934):909\u201313.","journal-title":"Nature"},{"issue":"1","key":"376_CR55","doi-asserted-by":"publisher","first-page":"e8825","DOI":"10.1371\/journal.pone.0008825","volume":"5","author":"M Rai","year":"2010","unstructured":"Rai M, Soragni E, Chou CJ, Barnes G, Jones S, Rusche JR, et al. Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich\u2019s ataxia patients and in a mouse model. PLoS ONE. 2010;5(1):e8825.","journal-title":"PLoS ONE"},{"issue":"4","key":"376_CR56","doi-asserted-by":"publisher","first-page":"e1958","DOI":"10.1371\/journal.pone.0001958","volume":"3","author":"M Rai","year":"2008","unstructured":"Rai M, Soragni E, Jenssen K, Burnett R, Herman D, Coppola G, et al. HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS ONE. 2008;3(4):e1958.","journal-title":"PLoS ONE"},{"issue":"10","key":"376_CR57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nchembio815","volume":"2","author":"D Herman","year":"2006","unstructured":"Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM. Histone deacetylase inhibitors reverse gene silencing in Friedreich\u2019s ataxia. Nat Chem Biol. 2006;2(10):551\u20138.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"376_CR58","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nbd.2011.02.016","volume":"42","author":"C Sandi","year":"2011","unstructured":"Sandi C, Pinto RM, Al-Mahdawi S, Ezzatizadeh V, Barnes G, Jones S, et al. Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011;42(3):496\u2013505.","journal-title":"Neurobiol Dis"},{"issue":"23","key":"376_CR59","doi-asserted-by":"publisher","first-page":"14588","DOI":"10.1074\/jbc.273.23.14588","volume":"273","author":"K Ohshima","year":"1998","unstructured":"Ohshima K, Montermini L, Wells RD, Pandolfo M. Inhibitory effects of expanded GAA. TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J Biol Chem. 1998;273(23):14588\u201395.","journal-title":"J Biol Chem"},{"issue":"4","key":"376_CR60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1097-2765(00)80474-8","volume":"3","author":"N Sakamoto","year":"1999","unstructured":"Sakamoto N, Chastain PD, Parniewski P, Ohshima K, Pandolfo M, Griffith JD, et al. Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich\u2019s ataxia. Mol Cell. 1999;3(4):465\u201375.","journal-title":"Mol Cell"},{"issue":"1","key":"376_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1086\/301680","volume":"62","author":"SI Bidichandani","year":"1998","unstructured":"Bidichandani SI, Ashizawa T, Patel PI. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and be associated with an unusual DNA structure. Am J Hum Genet. 1998;62(1):111\u201321.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"376_CR62","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1074\/jbc.M309596200","volume":"279","author":"M Napierala","year":"2004","unstructured":"Napierala M, Dere R, Vetcher A, Wells RD. Structure-dependent recombination hot spot activity of GAA.TTC sequences from intron 1 of the Friedreich\u2019s ataxia gene. J Biol Chem. 2004;279(8):6444\u201354.","journal-title":"J Biol Chem"},{"issue":"8","key":"376_CR63","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1074\/jbc.M309595200","volume":"279","author":"AA Vetcher","year":"2004","unstructured":"Vetcher AA, Wells RD. Sticky DNA formation in vivo alters the plasmid dimer\/monomer ratio. J Biol Chem. 2004;279(8):6434\u201343.","journal-title":"J Biol Chem"},{"issue":"42","key":"376_CR64","doi-asserted-by":"publisher","first-page":"39217","DOI":"10.1074\/jbc.M205209200","volume":"277","author":"AA Vetcher","year":"2002","unstructured":"Vetcher AA, Napierala M, Iyer RR, Chastain PD, Griffith JD, Wells RD. Sticky DNA, a long GAA.GAA.TTC triplex that is formed intramolecularly, in the sequence of intron 1 of the frataxin gene. J Biol Chem. 2002;277(42):39217\u201327.","journal-title":"J Biol Chem"},{"issue":"42","key":"376_CR65","doi-asserted-by":"publisher","first-page":"39228","DOI":"10.1074\/jbc.M205210200","volume":"277","author":"AA Vetcher","year":"2002","unstructured":"Vetcher AA, Napierala M, Wells RD. Sticky DNA: effect of the polypurine.polypyrimidine sequence. J Biol Chem. 2002;277(42):39228\u201334.","journal-title":"J Biol Chem"},{"key":"376_CR66","doi-asserted-by":"crossref","unstructured":"Burnett R, Melander C, Puckett JW, Son LS, Wells RD, Dervan PB, et al. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA.TTC repeats in Friedreich\u2019s ataxia. Proc Natl Acad Sci USA. 2006;103(31):11497\u2013502.","DOI":"10.1073\/pnas.0604939103"},{"issue":"9","key":"376_CR67","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1261\/rna.071290.119","volume":"25","author":"X Shen","year":"2019","unstructured":"Shen X, Beasley S, Putman JN, Li Y, Prakash TP, Rigo F, et al. Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression. RNA. 2019;25(9):1118\u201329.","journal-title":"RNA"},{"issue":"9","key":"376_CR68","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1039\/C9BM01757G","volume":"8","author":"E Czuba-Wojnilowicz","year":"2020","unstructured":"Czuba-Wojnilowicz E, Viventi S, Howden SE, Maksour S, Hulme AE, Cortez-Jugo C, et al. Particle-mediated delivery of frataxin plasmid to a human sensory neuronal model of Friedreich\u2019s ataxia. Biomater Sci. 2020;8(9):2398\u2013403.","journal-title":"Biomater Sci"},{"issue":"40","key":"376_CR69","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.scr.2019.101529","volume":"7","author":"J Li","year":"2019","unstructured":"Li J, Rozwadowska N, Clark A, Fil D, Napierala JS, Napierala M. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich\u2019s ataxia cardiomyocytes. Stem Cell Res. 2019;7(40):101529.","journal-title":"Stem Cell Res"},{"key":"376_CR70","doi-asserted-by":"crossref","unstructured":"Tuszynski MH, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer\u2019s disease. Prog Brain Res. 2004;146:441\u20139.","DOI":"10.1016\/S0079-6123(03)46028-7"},{"issue":"12","key":"376_CR71","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/gt.2015.102","volume":"22","author":"JC Glorioso","year":"2015","unstructured":"Glorioso JC, Cohen JB, Carlisle DL, Munoz-Sanjuan I, Friedlander RM. Moving toward a gene therapy for Huntington\u2019s disease. Gene Ther. 2015;22(12):931\u20133.","journal-title":"Gene Ther"},{"issue":"2","key":"376_CR72","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JPD-181331","volume":"8","author":"TM Axelsen","year":"2018","unstructured":"Axelsen TM, Woldbye DPD. Gene therapy for parkinson\u2019s disease, an update. J Parkinsons Dis. 2018;8(2):195\u2013215.","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"376_CR73","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1038\/tp.2016.186","volume":"6","author":"SS Jiao","year":"2016","unstructured":"Jiao SS, Shen LL, Zhu C, Bu XL, Liu YH, Liu CH, et al. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer\u2019s disease. Transl Psych. 2016;6(10):e907.","journal-title":"Transl Psych"},{"issue":"6","key":"376_CR74","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/sj.mt.6300143","volume":"15","author":"F Lim","year":"2007","unstructured":"Lim F, Palomo GM, Mauritz C, Gim\u00e9nez-Cassina A, Illana B, Wandosell F, et al. Functional recovery in a Friedreich\u2019s ataxia mouse model by frataxin gene transfer using an HSV-1 amplicon vector. Mol Ther. 2007;15(6):1072\u20138.","journal-title":"Mol Ther"},{"issue":"5","key":"376_CR75","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/mt.2016.32","volume":"24","author":"Y Katsu-Jim\u00e9nez","year":"2016","unstructured":"Katsu-Jim\u00e9nez Y, Lor\u00eda F, Corona JC, D\u00edaz-Nido J. Gene transfer of brain-derived neurotrophic factor (BDNF) prevents neurodegeneration triggered by FXN deficiency. Mol Ther. 2016;24(5):877\u201389.","journal-title":"Mol Ther"},{"issue":"4","key":"376_CR76","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/ijms22041815","volume":"22","author":"G Ocana-Santero","year":"2021","unstructured":"Ocana-Santero G, D\u00edaz-Nido J, Herranz-Mart\u00edn S. Future prospects of gene therapy for friedreich\u2019s ataxia. Int J Mol Sci. 2021;22(4):1815.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"376_CR77","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","volume":"20","author":"M Perdomini","year":"2014","unstructured":"Perdomini M, Belbellaa B, Monassier L, Reutenauer L, Messaddeq N, Cartier N, et al. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia. Nat Med. 2014;20(5):542\u20137.","journal-title":"Nat Med"},{"issue":"10","key":"376_CR78","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/gt.2011.45","volume":"18","author":"A Gimenez-Cassina","year":"2011","unstructured":"Gimenez-Cassina A, Wade-Martins R, Gomez-Sebastian S, Corona JC, Lim F, Diaz-Nido J. Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector. Gene Ther. 2011;18(10):1015\u20139.","journal-title":"Gene Ther"},{"issue":"2","key":"376_CR79","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/sj.mt.6300021","volume":"15","author":"S Gomez-Sebastian","year":"2007","unstructured":"Gomez-Sebastian S, Gimenez-Cassina A, Diaz-Nido J, Lim F, Wade-Martins R. Infectious delivery and expression of a 135 kb human FRDA genomic DNA locus complements Friedreich\u2019s ataxia deficiency in human cells. Mol Ther. 2007;15(2):248\u201354.","journal-title":"Mol Ther"},{"issue":"6","key":"376_CR80","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/mt.2015.41","volume":"23","author":"Y Li","year":"2015","unstructured":"Li Y, Polak U, Bhalla AD, Rozwadowska N, Butler JS, Lynch DR, et al. Excision of expanded GAA repeats alleviates the molecular phenotype of friedreich\u2019s ataxia. Mol Ther. 2015;23(6):1055\u201365.","journal-title":"Mol Ther"},{"issue":"15\u201316","key":"376_CR81","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/hum.2020.053","volume":"31","author":"J Li","year":"2020","unstructured":"Li J, Li Y, Wang J, Gonzalez TJ, Asokan A, Napierala JS, et al. Defining transcription regulatory elements in the human frataxin gene: implications for gene therapy. Hum Gene Ther. 2020;31(15\u201316):839\u201351.","journal-title":"Hum Gene Ther"},{"issue":"10","key":"376_CR82","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1093\/nar\/gkm271","volume":"35","author":"E Greene","year":"2007","unstructured":"Greene E, Mahishi L, Entezam A, Kumari D, Usdin K. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 2007;35(10):3383\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"2013","key":"376_CR83","first-page":"852080","volume":"19","author":"C Sandi","year":"2013","unstructured":"Sandi C, Al-Mahdawi S, Pook MA. Epigenetics in friedreich\u2019s ataxia: challenges and opportunities for therapy. Genet Res Int. 2013;19(2013):852080.","journal-title":"Genet Res Int"},{"issue":"3","key":"376_CR84","first-page":"554","volume":"59","author":"A Filla","year":"1996","unstructured":"Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996;59(3):554\u201360.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"376_CR85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/513887","volume":"61","author":"E Monr\u00f3s","year":"1997","unstructured":"Monr\u00f3s E, Molt\u00f3 MD, Mart\u00ednez F, Ca\u00f1izares J, Blanca J, V\u00edlchez JJ, et al. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet. 1997;61(1):101\u201310.","journal-title":"Am J Hum Genet"},{"issue":"5254","key":"376_CR86","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 MD, Pianese L, Coss\u00e9e M, Cavalcanti F, et al. Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423\u20137.","journal-title":"Science"},{"issue":"2","key":"376_CR87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(14)70321-7","volume":"14","author":"K Reetz","year":"2015","unstructured":"Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, et al. Biological and clinical characteristics of the European Friedreich\u2019s ataxia consortium for translational studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol. 2015;14(2):174\u201382.","journal-title":"Lancet Neurol"},{"issue":"11","key":"376_CR88","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","volume":"6","author":"V Campuzano","year":"1997","unstructured":"Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6(11):1771\u201380.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"376_CR89","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/jnnp.2003.028605","volume":"75","author":"L Pianese","year":"2004","unstructured":"Pianese L, Turano M, Lo Casale MS, De Biase I, Giacchetti M, Monticelli A, et al. Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers. J Neurol Neurosurg Psych. 2004;75(7):1061\u20133.","journal-title":"J Neurol Neurosurg Psych"},{"issue":"3","key":"376_CR90","doi-asserted-by":"publisher","first-page":"e17627","DOI":"10.1371\/journal.pone.0017627","volume":"6","author":"F Sacc\u00e0","year":"2011","unstructured":"Sacc\u00e0 F, Puorro G, Antenora A, Marsili A, Denaro A, Piro R, et al. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. PLoS ONE. 2011;6(3):e17627.","journal-title":"PLoS ONE"},{"issue":"2\u20133","key":"376_CR91","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ymgme.2010.07.001","volume":"101","author":"EC Deutsch","year":"2010","unstructured":"Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab. 2010;101(2\u20133):238\u201345.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"376_CR92","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrn.2016.46","volume":"17","author":"J Mertens","year":"2016","unstructured":"Mertens J, Marchetto MC, Bardy C, Gage FH. Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci. 2016;17(7):424\u201337.","journal-title":"Nat Rev Neurosci"},{"issue":"7284","key":"376_CR93","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S\u00fcdhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463(7284):1035\u201341.","journal-title":"Nature"},{"issue":"6","key":"376_CR94","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013;13(6):691\u2013705.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"376_CR95","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1038\/s41598-023-31144-3","volume":"13","author":"Y-C Hsueh","year":"2023","unstructured":"Hsueh Y-C, Pratt RE, Dzau VJ, Hodgkinson CP. Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2. Sci Rep. 2023;13(1):3920.","journal-title":"Sci Rep"},{"issue":"2","key":"376_CR96","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","volume":"72","author":"AH Koeppen","year":"2013","unstructured":"Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol. 2013;72(2):78\u201390.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"376_CR97","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ene.12350","volume":"21","author":"M Rossi","year":"2014","unstructured":"Rossi M, Perez-Lloret S, Doldan L, Cerquetti D, Balej J, Millar Vernetti P, et al. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur J Neurol. 2014;21(4):607\u201315.","journal-title":"Eur J Neurol"},{"issue":"6","key":"376_CR98","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2016.10.026","volume":"17","author":"Y Ishida","year":"2016","unstructured":"Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, et al. Vulnerability of purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs. Cell Rep. 2016;17(6):1482\u201390.","journal-title":"Cell Rep"},{"issue":"10","key":"376_CR99","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/nn.2638","volume":"13","author":"K Muguruma","year":"2010","unstructured":"Muguruma K, Nishiyama A, Ono Y, Miyawaki H, Mizuhara E, Hori S, et al. Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells. Nat Neurosci. 2010;13(10):1171\u201380.","journal-title":"Nat Neurosci"},{"issue":"4","key":"376_CR100","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.celrep.2014.12.051","volume":"10","author":"K Muguruma","year":"2015","unstructured":"Muguruma K, Nishiyama A, Kawakami H, Hashimoto K, Sasai Y. Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep. 2015;10(4):537\u201350.","journal-title":"Cell Rep"},{"issue":"7","key":"376_CR101","doi-asserted-by":"publisher","first-page":"150056","DOI":"10.1098\/rsob.150056","volume":"5","author":"LM Watson","year":"2015","unstructured":"Watson LM, Wong MMK, Becker EBE. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia. Open Biol. 2015;5(7):150056.","journal-title":"Open Biol"},{"issue":"7","key":"376_CR102","doi-asserted-by":"publisher","first-page":"11","DOI":"10.29245\/2572.942X\/2017\/7.1134","volume":"2","author":"MMK Wong","year":"2017","unstructured":"Wong MMK, Watson LM, Becker EBE. Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells. J Neurol Neuromed. 2017;2(7):11\u20135.","journal-title":"J Neurol Neuromed"},{"issue":"4","key":"376_CR103","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12311-017-0913-2","volume":"17","author":"LM Watson","year":"2018","unstructured":"Watson LM, Wong MMK, Vowles J, Cowley SA, Becker EBE. A simplified method for generating purkinje cells from human-induced pluripotent stem cells. Cerebellum. 2018;17(4):419\u201327.","journal-title":"Cerebellum"},{"issue":"8","key":"376_CR104","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fbioe.2020.00070","volume":"14","author":"TP Silva","year":"2020","unstructured":"Silva TP, Bekman EP, Fernandes TG, Vaz SH, Rodrigues CAV, Diogo MM, et al. Maturation of human pluripotent stem cell-derived cerebellar neurons in the absence of co-culture. Front Bioeng Biotechnol. 2020;14(8):70.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"376_CR105","doi-asserted-by":"publisher","first-page":"e55940","DOI":"10.1371\/journal.pone.0055940","volume":"8","author":"L Li","year":"2013","unstructured":"Li L, Voullaire L, Sandi C, Pook MA, Ioannou PA, Delatycki MB, et al. Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia. PLoS ONE. 2013;8(2):e55940.","journal-title":"PLoS ONE"},{"issue":"5","key":"376_CR106","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00415-015-7719-2","volume":"262","author":"EM Yiu","year":"2015","unstructured":"Yiu EM, Tai G, Peverill RE, Lee KJ, Croft KD, Mori TA, et al. Open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels. J Neurol. 2015;262(5):1344\u201353.","journal-title":"J Neurol"},{"issue":"13","key":"376_CR107","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddt115","volume":"22","author":"PK Chan","year":"2013","unstructured":"Chan PK, Torres R, Yandim C, Law PP, Khadayate S, Mauri M, et al. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich\u2019s ataxia can be reduced upon HDAC inhibition by vitamin B3. Hum Mol Genet. 2013;22(13):2662\u201375.","journal-title":"Hum Mol Genet"},{"key":"376_CR108","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nbd.2015.04.003","volume":"79","author":"LH Thompson","year":"2015","unstructured":"Thompson LH, Bj\u00f6rklund A. Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells. Neurobiol Dis. 2015;79:28\u201340.","journal-title":"Neurobiol Dis"},{"key":"376_CR109","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/sctm.20-0334","volume":"10","author":"S Viventi","year":"2021","unstructured":"Viventi S, Frausin S, Howden SE, Lim SY, Finol-Urdaneta RK, McArthur JR, et al. In vivo survival and differentiation of Friedreich ataxia iPSC-derived sensory neurons transplanted in the adult dorsal root ganglia. Stem Cells Transl Med. 2021;10:1157\u201369.","journal-title":"Stem Cells Transl Med"},{"issue":"413","key":"376_CR110","doi-asserted-by":"publisher","first-page":"eaaj2347","DOI":"10.1126\/scitranslmed.aaj2347","volume":"9","author":"CJ Rocca","year":"2017","unstructured":"Rocca CJ, Goodman SM, Dulin JN, Haquang JH, Gertsman I, Blondelle J, et al. Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich\u2019s ataxia. Sci Transl Med. 2017;9(413):eaaj2347.","journal-title":"Sci Transl Med"},{"issue":"17","key":"376_CR111","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.omtm.2020.04.018","volume":"12","author":"CJ Rocca","year":"2020","unstructured":"Rocca CJ, Rainaldi JN, Sharma J, Shi Y, Haquang JH, Luebeck J, et al. CRISPR-Cas9 gene editing of hematopoietic stem cells from patients with Friedreich\u2019s ataxia. Mol Ther Methods Clin Dev. 2020;12(17):1026\u201336.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-023-00376-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-023-00376-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:37:57Z","timestamp":1700390277000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-023-00376-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1186\/s40035-023-00376-8","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}